Demo Sign up Log In

Zevra Therapeutics Inc (ZVRA)

Cash Conversion Ratio

1.92×

Quarterly · Period ending: Jun 30, 2026

ZVRA Cash Conversion Ratio

Latest reported1.92×period endingJun 30, 2026

Latest reported1.92×period endingJun 30, 2026

ZVRA Quarterly Cash Conversion Ratio (-0.82× → 1.92×)

Latest values, visible window

High-resolution chart · PNG

ZVRA cash conversion ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Zevra Therapeutics Inc Cash Conversion Ratio — Quarterly
Period ending	Cash Conversion Ratio
Jun 30, 2026	1.9213×
Mar 31, 2026	0.1612×
Dec 31, 2025	0.456×
Sep 30, 2025	-7.6379×
Jun 30, 2025	-0.0511×
Mar 31, 2025	2.6851×
Dec 31, 2024	0.4547×
Sep 30, 2024	0.546×
Jun 30, 2024	0.959×
Mar 31, 2024	0.9725×
Dec 31, 2023	1.0711×
Sep 30, 2023	0.463×
Jun 30, 2023	3.3918×
Mar 31, 2023	0.3082×
Dec 31, 2022	0.4984×
Sep 30, 2022	1.0015×
Jun 30, 2022	0.1742×
Mar 31, 2022	1.8782×
Dec 31, 2021	0.32×
Sep 30, 2021	1.5543×
Jun 30, 2021	2.6635×
Mar 31, 2021	0.2512×
Dec 31, 2020	0.2234×
Sep 30, 2020	0.3493×
Jun 30, 2020	2.5576×
Mar 31, 2020	0.3533×
Dec 31, 2019	0.514×
Sep 30, 2019	-0.8225×

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.